HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats--time window and mechanism.

AbstractETHNOPHARMACOLOGICAL RELEVANCE:
Buyang Huanwu Decoction, a traditional Chinese medicine, consists of different herbal medicines, and has been traditionally used for centuries to treat paralysis and stroke. However, its optimal therapeutic time window and the mechanism are still unclear.
AIM OF THE STUDY:
This study was designed to explore the therapeutic time window and mechanism of Buyang Huanwu Decoction on transient focal cerebral ischemia/reperfusion injury.
MATERIALS AND METHODS:
Middle cerebral artery occlusion was conducted in male Sprague-Dawley rats, and 40g/kg of Buyang Huanwu Decoction was intragastrically infused at different time points, and the same dose was infused every 24h for 3 days. The level of glutamate in cerebrospinal fluid and the expression of metabotropic glutamate receptor-1 RNA in striatum were detected before, during, and after ischemia/reperfusion. Neurological deficit scores and brain infarction volumes were measured at 72h after reperfusion.
RESULT:
Cerebral ischemia/reperfusion resulted in significant neurological deficit and extensive cerebral infarct volume, associated with a large amount of glutamate in cerebrospinal fluid and elevation of metabotropic glutamate receptor-1 RNA expression. Buyang Huanwu Decoction significantly suppressed the release of glutamate, and reduced the expression of metabotropic glutamate receptor-1 RNA. The neurological defect score and infarction volume were significantly improved by administration of Buyang Huanwu Decoction, when compared with the Ischemia group.
CONCLUSIONS:
Administration of Buyang Huanwu Decoction, within 4h of post-transient focal stroke, reduced significant cerebral ischemia/reperfusion damage. The neuroprotective mechanism of Buyang Huanwu Decoction is, in part, associated with the down-regulation of metabotropic glutamate receptor-1 RNA and inhibition of glutamate release resulting from cerebral ischemia.
AuthorsLian-Dong Zhao, Jian-Hua Wang, Guang-Rong Jin, Ying Zhao, Hai-Jun Zhang
JournalJournal of ethnopharmacology (J Ethnopharmacol) Vol. 140 Issue 2 Pg. 339-44 (Mar 27 2012) ISSN: 1872-7573 [Electronic] Ireland
PMID22306289 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Drugs, Chinese Herbal
  • Neuroprotective Agents
  • RNA, Messenger
  • Receptors, Metabotropic Glutamate
  • buyang huanwu
  • Glutamic Acid
Topics
  • Animals
  • Cerebral Infarction (prevention & control)
  • Cerebrovascular Disorders
  • Drugs, Chinese Herbal (pharmacology, therapeutic use)
  • Glutamic Acid (cerebrospinal fluid)
  • Ischemic Attack, Transient (drug therapy, metabolism)
  • Magnoliopsida
  • Male
  • Nervous System Diseases (prevention & control)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Oligochaeta
  • Phytotherapy
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Metabotropic Glutamate (genetics, metabolism)
  • Reperfusion Injury (metabolism, prevention & control)
  • Stroke (drug therapy, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: